Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026

Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026 Accessibility Statement Skip NavigationNEW YORK, March 9, 2026 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced its successful strategic showcase at the 2026 North American Society for Interventional Thyroidology (NASIT) in Portland, Oregon. This engagement advances the Company ...